Latest news with #SBIR
Yahoo
3 days ago
- Business
- Yahoo
Berkshire Biomedical Awarded NIH Research Grant to Support Clinical Study Program to Evaluate Patient Retention and Other Benefits of the COPA™ System for Take-Home Methadone Medication Management
Funds from the Two-Phase Fast-Track SBIR Grant, Combined, Would Total Approximately $2.9 Million DALLAS, June 2, 2025 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, today announced that it has been awarded the first phase of a two-phase Fast-Track Small Business Innovation Research (SBIR) grant (1 R44DA061908-01A1) from the National Institutes of Health's (NIH) National Institute of Drug Abuse (NIDA). Valued at approximately $2.9 million over 30 months, the two-phase grant will support execution of a clinical study to evaluate patient retention and other benefits of the Company's COPA™ System for Take-Home Methadone Medication Management as part of Medication for Opioid User Disorder (MOUD) treatment. Phase I funds of approximately $326,400 will support the execution of a single-site study. Receipt of the approximate $2.55 million Phase II award will support the execution of an open-label, randomized, parallel multi-site study, which will be contingent on an assessment of the Phase I report, as well as the review and approval of any other documentation necessary for continuation and availability of NIH funds. COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only an Authenticated Intended User (AIU™), upon confirmation of dual biometric identifications (fingerprint and dentition) prior to each dose, with the goal of enhancing patient wellness and providing remote monitoring. "The Fast-Track SBIR grant process is highly competitive, with only 18% of applicants having been chosen under this program in 2023, alone," stated John Timberlake, Chief Executive Officer of Berkshire. This is Berkshire's second Fast-Track SBIR Grant from NIH. The Company received an initial two-phased award totaling $2.2 million (1R44DA057185) in 2022 which extended through 2024, to complete the development of the COPA system. Berkshire's receipt of this newest award reflects the NIH's continued belief in the strength of the technology behind COPA and its potential to significantly increase access to Opioid Treatment Programs for persons suffering from Opioid Use Disorder (OUD) by dramatically increasing the number of persons being allowed to utilize take home therapy." Mr. Timberlake continued, "The requirement to travel to an Opioid Treatment Program (OTP) clinic, daily, has been shown to reduce treatment retention and deter some patients from even starting treatment. A mixed methods study found that take-home dose flexibility among stable patients was associated with receiving more take homes, higher rates of treatment retention, and lower rates of opioid-positive drug tests. Higher retention rates in opioid use disorder medication among patients with OUD were, therefore, associated with better outcomes. There have been a considerable number of retrospective studies evaluating opioid use disorder treatment retention; however, there are very few prospective comparison studies." About the National Institute on Drug Abuse (NIDA)NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit About the National Institutes of Health (NIH)NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit About Berkshire Biomedical Corporation Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with encrypted HIPAA compliant cloud-based and healthcare provider-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU). The Company's lead product under development, the Computerized Oral Prescription Administration System (COPA), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the AIU upon confirmation of dual biometric identification (fingerprint and dentition). Upon receiving regulatory authorization, the Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of oral liquid medication methadone, for Medication Use for Opioid Use Disorder treatment and subsequently for the delivery of controlled medications for the treatment of pain, as those patients have the greatest need for the benefits of COPA's features. In addition, the Company will look to expand COPA use in broader drug therapeutic categories, clinical applications, and businesses that manage the commercialization and data analytics provided by electronic devices to improve outcomes and reduce risk. Additional information about Berkshire Biomedical and the COPA System can be found at The COPA™ System is currently under development, has NOT been reviewed by the U.S. Food and Drug Administration and is not available for commercial sale. Disclaimer: Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Numbers R44DA057185 and R44DA061908-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CONTACT: Berkshire Biomedical Corporationinfo@ Melody CareyFounder, President, and CEORx Communications Group, LLCmcarey@ View original content: SOURCE Berkshire Biomedical Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
Base Operations selected by the US Air Force to provide AI-driven security intelligence for mission resilience and force protection
The Direct-to-Phase II contract was awarded to identify, assess, predict and counter emerging threats, including Small Unarmed Aerial Systems incursions, when operating in dynamic environments with limited intelligence and evolving adversary tactics. WASHINGTON, May 27, 2025 /PRNewswire/ -- Base Operations has been selected by AFWERX for a Direct-to-Phase II contract focused on decoding local threats and providing actionable insights to safeguard the global operations of the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on May 27th 2025, Base Operations will take the next step in its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. "In an era of evolving threats and rapid transformation in federal procurement, sourcing cutting-edge solutions from U.S. startups is essential to maintaining operational readiness and protecting the warfighter. Base Operations is proud to be selected by the Air Mobility Command of the Department of Air Force to deliver advanced, AI-powered threat intelligence. Our platform enhances force protection by anticipating and mitigating risks around critical installations, safeguarding personnel, and effectively countering adversarial foreign espionage. By equipping decision-makers with AI-driven insights, we help strengthen operational resilience and ensure mission success in complex and dynamic environments." Cory Siskind, Founder & CEO at Base Operations The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. About Base OperationsBase Operations decodes the world's threat landscape into actionable security insights that enable organizations to protect their people, assets, and operations. Identify and assess threats, manage risk across your footprint, and make data-driven decisions using granular, street-level intelligence at global scale. Learn more at About AFRLThe Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit About AFWERXAs the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at four hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has awarded over 10,400 contracts worth more than $7.24 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: For press enquiries contact ben@ View original content to download multimedia: SOURCE Base Operations Sign in to access your portfolio
Yahoo
27-05-2025
- Business
- Yahoo
Zulu Pods Successfully Demonstrates ZPOD Oil Delivery Technology on Acutronic Turbojet Engine; Secures Additional Navy Funding for Continued Development
FT. LAUDERDALE, Fla., May 27, 2025 /PRNewswire/ -- Zulu Pods, Inc. (ZPI), a leading innovator in fluid delivery systems, announced the successful demonstration of its once-through, minimal oil delivery technology—the ZPOD—on Acutronic Turbines Inc.'s 70-pound thrust class attritable turbojet engine. Conducted at Acutronic's test facility in Austin, Texas, the engine ground test validated a double-digit percentage reduction in Thrust Specific Fuel Consumption (TSFC) compared to traditional fuel-lubricated configurations. The demonstration marks a significant milestone in ZPI's mission to increase engine performance and efficiency for expendable propulsion systems. "This test proves that the ZPOD can enhance performance while simplifying lubrication for single-use engines," said ZPI Co-Founder and CEO, Rob Sladen. "It's a game changer for the growing class of attritable and expendable platforms." As a continuation of its work with the U.S. Navy, ZPI has been awarded the second tranche of its SBIR Phase II contract. This funding will enable joint collaboration with Acutronic on a second engine configuration, designed to support a range of national defense programs. Building on their momentum, ZPI and Acutronic have agreed to conduct flight testing with the ZPOD later this year, a move that will advance the technology to Technology Readiness Level (TRL) Eight. This flight campaign will further validate the ZPOD in operationally relevant conditions, cementing its viability for defense applications. The year ahead is pivotal for Zulu Pods as the company accelerates its commercialization roadmap. In Q2 alone, ZPI is scheduled to deliver ZPODs for evaluation at seven separate customer facilities. Concurrently, the company has initiated qualification activities with multiple Department of Defense stakeholders to ensure compliance with military specifications. "Our 2025 pipeline is a strong indicator of market demand for compact, high-efficiency oil delivery systems," said Sladen. "From decoys to loitering munitions and other expendable platforms, we're excited to help shape the future of propulsion for the modern warfighter." About Zulu Pods, Inc. Zulu Pods, Inc. (ZPI) designs and manufactures innovative fluid delivery solutions for drones and missiles, rotorcraft, and anti-corrosion applications with a mission to enhance the US Military's warfighting capabilities for modern challenges. ZPI's products radically simplify mechanical system architectures resulting in improved mission performance, safety, reliability, and optimized fleet maintenance. About The Acutronic Group Acutronic manufactures specialty components for use on uncrewed aerial vehicles, land defense applications, and missile systems. These products are used on next-generation aerospace programs and include a range of electric power systems, servo-actuators, micro-turbines, and Hybrid-Electric-Propulsion-Systems. Acutronic offers standard products and excels at designing highly customized solutions for demanding mission requirements. View original content to download multimedia: SOURCE Zulu Pods Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
20-05-2025
- Business
- Business Wire
RISE Robotics Awarded U.S. Army Phase I Contract to Explore Advanced Collapsible Lightweight Crane Technology
SOMERVILLE, Mass.--(BUSINESS WIRE)--RISE Robotics, a leader in next-generation actuation technologies, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Army to explore the feasibility of developing collapsible, ultra-lightweight cranes for rapid deployment in resource-constrained and expeditionary environments. The eight-month, $250,000 contract is sponsored by Letterkenny Army Depot and was awarded under the Army's Mobile Sustainment Tools Open Topic (A244-P056). The effort aims to evaluate how RISE's proprietary Beltdraulic™ actuation system can be leveraged to develop portable structural systems that are easy to transport, quick to assemble, and capable of withstanding harsh conditions. 'This effort reflects the Army's growing focus on enabling rapid mobility and logistical efficiency in the field,' said Tom Phelps, COO of RISE Robotics. 'With this Phase I award, we're excited to explore how our Beltdraulic technology can address critical operational gaps through lighter, more agile lifting equipment.' The Phase I work builds on RISE's proven track record of delivering defense-grade lifting systems. RISE previously completed a Phase III production contract with the U.S. Air Force for the Common Lifting Device (CLD), a compact, electronic-free lift system developed to support the MC-130J Silent Knight Radar program. The CLD features a lift capacity of 200 pounds, a maximum lift height of 11 feet 10 inches, and a total system weight of just 215 pounds, all within a 6'X3'X3" footprint. Its successful transition to production highlights RISE's ability to deliver innovative, field-deployable solutions at scale. Under this new Army contract, RISE will investigate how its CLD platform and Beltdraulic architecture can be adapted to meet Army-specific needs. This includes exploring structural modifications, such as moving boom-type crane arms, evaluating the use of larger wheels for off-road mobility, and developing design variants for lower-profile lifting use cases. RISE team members will engage directly with Army personnel to gather operational insights and define mission-driven requirements for future development. The Phase I effort will include demonstrating CLD capabilities to Army stakeholders, developing a tailored requirements document based on end-user feedback, and a roadmap identifying high-impact Army applications for a next-generation collapsible crane. The outcome will help shape a potential Phase II program to deliver a prototype that meets expeditionary mission requirements. For more information about RISE Robotics and its advanced lifting technologies, visit About RISE Robotics: RISE Robotics is transforming industrial actuation with Beltdraulic™, a fluid-free linear actuator technology that delivers hydraulic-like power without the disadvantages. Using a belt-and-pulley system instead of oil, Beltdraulic enhances mission readiness by cutting fuel consumption (and associated logistical costs) in half, eliminating exposure of personnel to pollutants, and significantly reducing maintenance and manpower requirements. RISE is a Reg CF company, allowing both accredited and non-accredited investors to own a piece of its innovative technology through Wefunder.
Yahoo
19-05-2025
- Automotive
- Yahoo
Yank Technologies Selected for Prestigious NASA Phase II Contract for Dust-Tolerant Resonant Connectors
Yank Technologies collaborates with NASA for power interfacing solutions on lunar and planetary surfaces. BROOKLYN, N.Y., May 19, 2025 /PRNewswire/ -- Yank Technologies, the developer of disruptive long range, high power wireless charging solutions, has been selected for a two-year follow-on Small Business Innovation Research (SBIR) Phase II contract from the National Aeronautics and Space Administration (NASA) to advance Dust-Tolerant Resonant Connectors for lunar and planetary surfaces. Dust-Tolerant Resonant Connectors are extremely efficient interlocking coils for robust power transmission on the Moon and Mars. They are completely insulated with no exposed conductive terminals to operate effectively in extremely dusty and dirty environments, making them ideal for space exploration. With the extreme conditions of the Moon and Mars, traditional connectors are subject to unreliable mating and physical wear and tear over time. Dust-Tolerant Resonant Connectors are designed to withstand the roughest environmental conditions. Leveraging their wireless power expertise, Yank Technologies has successfully delivered Dust-Tolerant Resonant Connectors to NASA and will be advancing these products for future NASA missions. Yank Technologies develops customizable wireless power solutions for industrial, automotive, consumer, and space applications. With eighteen patents granted and approximately fifty pending, Yank Technologies eliminates unreliable electrical connections to strengthen durability, increase operational efficiency, and enable new product features. Their industrial solutions enhance robotic autonomy in factories by charging AMRs enroute to reduce downtime and by wirelessly powering and communicating quality control test functions in real-time. They also develop functionally expandable wireless power solutions to enable new product features in next-generation vehicle interiors. These solutions decrease assembly and warranty costs by eliminating complex wire harness connections enabling new features like seamless door removal and complete cockpit reconfiguration. Furthermore, Yank Technologies is reimagining the consumer experiences by charging multiple electronics over the air, in cupholders, and on table-tops. For the 2025 fiscal year, the US House of Representatives allocated $7.8 billion to NASA's Artemis I Program to return humans to the moon. With the increasing demand in Moon exploration, Yank Technologies has the opportunity to expand their wireless power ecosystem for space applications. With this Phase II contract, Yank Technologies will advance their Dust-Tolerant Resonant Connector system for power transmission lines and umbilical products from landers on the Moon and Mars. The Phase II development will optimize the size, weight, and power for kilowatt applications and will be verified with lunar and planetary regolith to be infused into upcoming NASA missions. "With this follow-on NASA Phase II contract, we will prepare Dust-Tolerant Resonant Connectors for a variety of power interfacing solutions for NASA to establish long-lasting habitats on the Moon and Mars," said Josh Yank, CEO of Yank Technologies. To learn more about Yank Technologies or inquire about their wireless power solutions, please visit About Yank TechnologiesYank Technologies, Inc. is a wireless power innovator based in New York committed to developing long-range, high power wireless charging technology that is safe, simple and requires no human contact. Yank Tech has patented antenna and amplifier developments in resonant inductive technology, and provides scalable solutions for variable ranges of power and distances. For more information visit: Media Contact:Josh YankChief Executive Officermedia@ View original content to download multimedia: SOURCE Yank Technologies Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
